Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo.
about
Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Deferasirox, an oral iron chel ...... l growth in vitro and in vivo.
@en
Deferasirox, an oral iron chel ...... l growth in vitro and in vivo.
@nl
type
label
Deferasirox, an oral iron chel ...... l growth in vitro and in vivo.
@en
Deferasirox, an oral iron chel ...... l growth in vitro and in vivo.
@nl
prefLabel
Deferasirox, an oral iron chel ...... l growth in vitro and in vivo.
@en
Deferasirox, an oral iron chel ...... l growth in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Deferasirox, an oral iron chel ...... ll growth in vitro and in vivo
@en
P2093
Hirofumi Harima
Isao Sakaida
Koichi Fujisawa
Naoki Yamamoto
Seiji Kaino
Shogo Amano
Shuhei Shinoda
Takahiro Yamasaki
Taro Takami
Toshihiko Matsumoto
P2860
P304
28434-28444
P356
10.18632/ONCOTARGET.25421
P407
P577
2018-06-19T00:00:00Z